Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years
Akeso’s Clinical Trial Results for Ivonescimab in Advanced Lung Cancer
Akeso, the Chinese biotechnology company whose drug ivonescimab was hailed as “biotech’…